contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


arets-meddelelse-nr-8-blue-vison-as-storaktionaermeddelelse

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Pharma Equity Group udvikler nye lægemidler til lokalbehandling af alvorlige og livstruende betændelsessygdomme hvor der i dag ikke findes en tilstrækkelig behandling. Selskabet benytter sig af repositionering af eksisterende lægemidler og fører lægemiddelkandidater frem til et klinisk fase III stadie hvorefter det overgives til en strategisk partner, der vil færdigudvikle produkterne og bringe dem på markedet, enten selvstændigt eller i samarbejde med selskabet.

Pharma Equity Group

Dato: 2. juni 2020 Årets meddelelse nr.: 8 BLUE VISON A/S – STORAKTIONÆRMEDDELELSE Blue Vision A/S har i dag modtaget vedlagte meddelelse. Med venlig hilsen Blue Vision A/S Peter Ole Jensen ...

Dato: 2. juni 2020 Årets meddelelse nr.: 8 BLUE VISON A/S – STORAKTIONÆRMEDDELELSE Blue Vision A/S har i dag modtaget vedlagte meddelelse. Med venlig hilsen Blue Vision A/S Peter Ole Jensen SENDT PR. E-MAIL: POJ@BLUEVISION.DK Blue-Vision A/S Kære Peter, Att. Blue Vision A/S Kjøller A/S er i går d. 1/6-2022 har gennemført salgsordrer og faldet under grænsen for at være storaktionær i Blue Vision A/S, idét aktiebesiddelsen nu udgør under 5%.&nbsp; Kjøller A/S besidder i dag 249.818 stk. A-aktier og 541.984 stk. B-aktier. Kjøller A/S har hermed givet meddelelse til selskabet.&nbsp; <table style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; margin-left:5.4pt; width:210pt; border-collapse:collapse ;"><tbody><tr><td style="width:280px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: middle ;">Med venlig hilsen / Best regards</td></tr><tr><td style="width:280px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: middle ;">&nbsp;</td></tr><tr><td style="width:280px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: middle ;">Jens Christian Thordal Poulsen</td></tr><tr><td style="width:280px;;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: middle ;">Legal Counsel</td></tr></tbody></table> <img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMDY1NzAwMSM0MDEyNjQxMjIjMjA5MTUzMQ=="> <img src="https://ml-eu.globenewswire.com/media/OWI4Y2Y0ZDUtYzZiOC00MWQ3LWIxOTctYWY0MjdkMTQwY2FiLTExMDMxMDI=/tiny/Blue-Vision.png">